NO20020573D0 - Sekvens - Google Patents

Sekvens

Info

Publication number
NO20020573D0
NO20020573D0 NO20020573A NO20020573A NO20020573D0 NO 20020573 D0 NO20020573 D0 NO 20020573D0 NO 20020573 A NO20020573 A NO 20020573A NO 20020573 A NO20020573 A NO 20020573A NO 20020573 D0 NO20020573 D0 NO 20020573D0
Authority
NO
Norway
Prior art keywords
isav
acid sequences
sequences
sequence
salmonids
Prior art date
Application number
NO20020573A
Other languages
English (en)
Other versions
NO20020573L (no
NO328740B1 (no
Inventor
Steven Griffiths
Rachel Jane Ritchie
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20020573(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9918588.6A external-priority patent/GB9918588D0/en
Priority claimed from GB0005848A external-priority patent/GB0005848D0/en
Priority claimed from GB0006674A external-priority patent/GB0006674D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20020573D0 publication Critical patent/NO20020573D0/no
Publication of NO20020573L publication Critical patent/NO20020573L/no
Publication of NO328740B1 publication Critical patent/NO328740B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Color Image Communication Systems (AREA)
  • Saccharide Compounds (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20020573A 1999-08-07 2002-02-05 Sammensetninger og vaksine, samt anvendelse av sammensetningene for fremstilling av en vaksine for beskyttelse av fisk mot infeksiøs lakseanemivirus NO328740B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9918588.6A GB9918588D0 (en) 1999-08-07 1999-08-07 Sequence
GB0005848A GB0005848D0 (en) 2000-03-11 2000-03-11 Sequence
GB0006674A GB0006674D0 (en) 2000-03-21 2000-03-21 Sequence
PCT/GB2000/002976 WO2001010469A2 (en) 1999-08-07 2000-08-07 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines

Publications (3)

Publication Number Publication Date
NO20020573D0 true NO20020573D0 (no) 2002-02-05
NO20020573L NO20020573L (no) 2002-04-05
NO328740B1 NO328740B1 (no) 2010-05-03

Family

ID=27255591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020573A NO328740B1 (no) 1999-08-07 2002-02-05 Sammensetninger og vaksine, samt anvendelse av sammensetningene for fremstilling av en vaksine for beskyttelse av fisk mot infeksiøs lakseanemivirus

Country Status (12)

Country Link
US (7) US6919083B1 (no)
EP (2) EP1200132B2 (no)
AT (1) ATE332712T1 (no)
AU (1) AU6304100A (no)
CA (1) CA2378437C (no)
CY (1) CY1106175T1 (no)
DE (1) DE60029327T2 (no)
DK (2) DK1200132T4 (no)
ES (1) ES2267553T3 (no)
NO (1) NO328740B1 (no)
PT (1) PT1200132E (no)
WO (1) WO2001010469A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2267553T3 (es) 1999-08-07 2007-03-16 Novartis Ag Secuencias de acidos nucleicos y de aminoacidos del virus de la anemia infecciosa del salmon y sus usos como vacunas.
EP1094069B2 (en) * 1999-10-18 2008-04-23 Intervet International BV DNA encoding structural protein-1 of infectious salmon anaemia virus and uses thereof
WO2001066569A1 (en) * 2000-03-08 2001-09-13 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
AU2001295584A1 (en) * 2000-09-28 2002-04-08 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus
GB0216414D0 (en) * 2002-07-15 2002-08-21 Novartis Ag Organic compounds
US8753878B2 (en) 2006-12-22 2014-06-17 Ewos S.A. Process and formulation for immunizing fish in aquaculture systems
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
WO2013151662A2 (en) * 2012-03-09 2013-10-10 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311648B1 (no) 1999-05-31 2001-12-27 Genomar Asa DNA-sekvenser som kan benyttes til vaksine, forebyggende helsearbeid på fisk og akvatiske organismer og ellers innenbiomedisin, vektor, vaksine mot ILA-virus samt diagnostisk sett
ES2267553T3 (es) 1999-08-07 2007-03-16 Novartis Ag Secuencias de acidos nucleicos y de aminoacidos del virus de la anemia infecciosa del salmon y sus usos como vacunas.
EP1094069B2 (en) 1999-10-18 2008-04-23 Intervet International BV DNA encoding structural protein-1 of infectious salmon anaemia virus and uses thereof
WO2001049712A2 (en) 2000-01-07 2001-07-12 Akzo Nobel N.V. Vaccine against isav (infectious salmon anaemia virus)
WO2001066569A1 (en) 2000-03-08 2001-09-13 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
AU2001295584A1 (en) 2000-09-28 2002-04-08 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus

Also Published As

Publication number Publication date
EP1200132B1 (en) 2006-07-12
US20040146860A1 (en) 2004-07-29
DK200200167A (da) 2002-04-02
ATE332712T1 (de) 2006-08-15
CA2378437C (en) 2014-01-21
DK1200132T4 (da) 2010-04-19
US20050261227A1 (en) 2005-11-24
US6919083B1 (en) 2005-07-19
EP1637614A2 (en) 2006-03-22
US20070041988A1 (en) 2007-02-22
CA2378437A1 (en) 2001-02-15
WO2001010469A2 (en) 2001-02-15
US20050164176A1 (en) 2005-07-28
NO20020573L (no) 2002-04-05
CY1106175T1 (el) 2011-06-08
ES2267553T3 (es) 2007-03-16
DK1200132T3 (da) 2006-10-23
EP1200132B2 (en) 2010-02-17
NO328740B1 (no) 2010-05-03
US7201910B2 (en) 2007-04-10
EP1637614A3 (en) 2006-11-29
EP1200132A2 (en) 2002-05-02
DE60029327T2 (de) 2007-07-05
DE60029327D1 (de) 2006-08-24
DK177298B1 (en) 2012-10-15
US7128917B2 (en) 2006-10-31
US20120071630A1 (en) 2012-03-22
PT1200132E (pt) 2006-11-30
AU6304100A (en) 2001-03-05
US7199108B2 (en) 2007-04-03
US7998484B2 (en) 2011-08-16
US20100136038A1 (en) 2010-06-03
WO2001010469A3 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
ATE118352T1 (de) Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
ES2095852T3 (es) Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c.
DE60010285D1 (de) Verfahren zur Herstellung von Amino-Oxide
SG144692A1 (en) Antigenic proteins of shrimp white spot syndrome virus and uses thereof
NO20020573D0 (no) Sekvens
ATE495247T1 (de) Chromoprotein und fluoroproteine
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
ATE447612T1 (de) Fluoreszenzproteine
ATE461453T1 (de) Nukleinsäuresequenz und protein, das eine rolle bei der zellulären alterung spielt
DE69939114D1 (de) Nukleinsäuresequenzfamilie und entsprechende proteinsequenzen, die humane endogene retrovirale motive enthalten, und ihre anwendungen
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
NO20005217L (no) DNA som koder for strukturelt protein-1 i infeksiös lakseanemivirus og anvendelse derav
ATE484582T1 (de) Aus koji-schimmelpilz stammende phospholipase a2
ATE388231T1 (de) Fischimpstoff gegen piscirickettsia salmonis
DE50206201D1 (de) Verfahren zur Herstellung von Styrylfarbstoffen
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
ITMI20000344A0 (it) Peptidi tlp e sequenze di dna che li codificano
TH40453A (th) ยีน dtsR ที่ไวต่ออุณหภูมิ
ZA982996B (en) Synthetic peptides which can be used in biological tests for the detection of infections due to group O HIV-1 viruses.
RU2003121321A (ru) Синтетический антиген на основе сополимеров n-винилпирролидона, кротоновой кислоты и n-кротоноиламинофенола, содержащий ковалентно присоединенный 2-нафтиламин в качестве гаптена

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: NOVARTIS TIERGESUNDHEIT AG, CH

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ELANCO TIERGESUNDHEIT AG, CH

MK1K Patent expired